Erez Raphael - Jul 15, 2021 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Erez Raphael
Stock symbol
DRIO
Transactions as of
Jul 15, 2021
Transactions value $
-$22,913
Form type
4
Date filed
7/19/2021, 05:51 PM
Previous filing
May 20, 2021
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRIO Common Stock Sale -$22.9K -1.3K -0.14% $17.63* 943K Jul 15, 2021 Direct F1, F2
holding DRIO Common Stock 37.9K Jul 15, 2021 By Dicilyon Consulting and Investment Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $17.78, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3 The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.